COPD and Asthma Pharma Flashcards
Beta receptors are what kind of receptor?
GPCR
What does activation of beta-2 receptors in the lung do?
relaxation of airway smooth muscle and bronchodilation
What are SABA’s used for?
immediate relief of symptoms, have an onset of action of 5 to 15 minutes, and generally last 4-6 hours.
What are LABA’s used for?
last up to 24 hours and are used for long-term control of COPD and asthma.
What is important to check in someone who uses an inhaler?
Their technique! even with good technique, only 10% of inhaled medications are deposited
side effects include tremor, palpitations, tachycardia, hypokalemia, hyperglycemia, and lactic acidosis. Which drug is this?
beta receptor agonists
What are LABAs indicated for in COPD?
group B, C or D alone in or with ICS
How should COPD with persistent dyspnea on one bronchodilator be managed?
Add another bronchodilator (i.e. LABA and LAMA)
LABA’s are monotherapy for: COPD or asthma
COPD
NOT indicated for asthma first line monotherapy (that’s ICS)
Which subclass of muscarinic receptors are targeted by LAMAs and SAMAs?
M3
What does binding of acetylcholine at the M3 receptor do?
release intracellular calcium and bronchoconstriction
How do muscarinic receptor antagonists work?
Inhaled muscarinic antagonists competitively and reversibly inhibit the effects of acetylcholine on the M3 muscarinic receptor on airway smooth muscle cells causing bronchodilation.
What are adverse effects of muscarinic antagonists?
Potential side effects include dry mouth, constipation, urinary retention, and precipitation of narrow angle glaucoma. Be aware of other anticholinergic medications your patient is taking.
What is the indication for muscarinic antagonist use in COPD?
Per GOLD guidelines, LAMAs (either alone or in combination with a LABA and/or inhaled corticostertoid) are indicated for groups B, C, and D COPD.
What is the indication for muscarinic antagonist use in asthma?
Per GINA guidelines, LAMAs can be considered at step 4 or 5 in patients who continue to have exacerbations despite a medium or high dose ICS + LABA.